MRI-defined T3, clear mesorectal fascia mid-low rectal cancer: is neoadjuvant treatment necessary?
Ziwei ZengZe LiShuangling LuoLiang HuangZhenxing LiangXiaobin ZhengWenxin LiLi XiongHuashan LiuLiang KangPublished in: Journal of gastroenterology and hepatology (2024)
Surgery alone versus nCRT followed by surgery may provide similar long-term oncological outcomes for patients with MRI-defined T3, clear MRF, and mid-low rectal cancer. nCRT may cause overtreatment in some patients.
Keyphrases
- rectal cancer
- locally advanced
- minimally invasive
- coronary artery bypass
- magnetic resonance imaging
- contrast enhanced
- ejection fraction
- newly diagnosed
- surgical site infection
- prognostic factors
- radiation therapy
- diffusion weighted imaging
- prostate cancer
- squamous cell carcinoma
- type diabetes
- patient reported outcomes
- computed tomography
- skeletal muscle
- adipose tissue
- metabolic syndrome
- robot assisted